Product

Oxylanthanum Carbonate

Aliases

OLC

1 clinical trial

1 indication

Indication

Chronic Kidney Disease Requiring Chronic Dialysis

Clinical trial

A Multicenter, Multidose, Study to Assess the Tolerability and Pharmacokinetics of Oxylanthanum Carbonate at Clinically Effective Doses in Patients With Chronic Kidney Disease on Dialysis

Status: Active (not recruiting), Estimated PCD: 2024-03-31